Kyntra Bio Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Kyntra Bio Inc inventory turnover ratio, the Kyntra Bio Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.22 in the first quarter 2026, KYNB's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Kyntra Bio Inc in Mar 31 2026 quarter, has decreased to 299 days, compare to 2028 days, in the Dec 31 2025 quarter.

Within Healthcare sector 292 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the fourth quarter 2025, to 1568.

KYNB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Kyntra Bio Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

KYNB Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	7.26 %	18.64 %	-83.86 %	-84.79 %	-88.46 %
Y / Y Cost of Sales Growth	1529.37 %	-	-98.9 %	-98.36 %	-99.02 %
Inventory Turnover Ratio (TTM)	1.22	0.18	-1.55	-0.03	0.35
KYNB's Total Ranking	# 1568	# 0	#	#	#
Average inventory processing period	299	1983	-235	-14545	1041
Seq. Inventory Growth	-9.59 %	-3.13 %	0.03 %	22.44 %	0 %
Seq. Cost of Sales Growth	1376.98 %	379.31 %	-31.76 %	-66.27 %	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 81
Healthcare Sector	# 293
Overall Market	# 1568

Inventory Turnover Ratio Statistics
High	Average	Low
1.52	0.6	-1.55
(Dec 31 2024)		(Sep 30 2025)

KYNB Company Profile >> Back to KYNB Efficiency Comparisons >> Compare KYNB Inventory Turnover Ratio to its Competitors

Financial Statements
Kyntra Bio Inc 's Inventories	$ 3 Millions	Visit KYNB's Balance sheet
Kyntra Bio Inc 's Cost of Revenues TTM	$ 5 Millions	Visit KYNB's Income Statement
What are KYNB's Sales?		Visit KYNB's Sales by Segment

Other Inventory Turnover Ratios
Kyntra Bio Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
KYNB's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for KYNB's Competitors
Inventory Turnover Ratio for KYNB's Suppliers
Inventory Turnover Ratio for KYNB's Customers

You may also want to know
KYNB's Sales Growth Rates	KYNB's Pe Price to earnings ratio	KYNB's Receivables Turnover Ratio	KYNB's Stock Quote
KYNB's Net Income Growth Rates	KYNB's Ps Price to Sales ratio	KYNB's Sales per Employee	KYNB's Asset Turnover Ratio
KYNB's Net Margin	KYNB's Pb Price to Book ratio	KYNB's Financial Strength Ratios	KYNB's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Biocryst Pharmaceuticals Inc	3.67	$ 19.884 Millions	$ 5 Millions
Neuraxis Inc	3.61	$ 0.665 Millions	$ 0 Millions
Mirum Pharmaceuticals Inc	3.50	$ 85.221 Millions	$ 24 Millions
Tandem Diabetes Care Inc	3.42	$ 457.823 Millions	$ 134 Millions
Exelixis Inc	3.41	$ 84.478 Millions	$ 25 Millions
Baxter International Inc	3.37	$ 7,911.000 Millions	$ 2,348 Millions
Gilead Sciences Inc	3.36	$ 6,139.000 Millions	$ 1,825 Millions
Maravai Lifesciences Holdings Inc	3.33	$ 143.875 Millions	$ 43 Millions
Intelligent Bio Solutions Inc	3.31	$ 2.064 Millions	$ 1 Millions
Cadre Holdings inc	3.28	$ 372.000 Millions	$ 113 Millions
Agilent Technologies inc	3.27	$ 3,418.000 Millions	$ 1,047 Millions
Solventum Corporation	3.23	$ 3,363.000 Millions	$ 1,042 Millions
Biofrontera Inc	3.22	$ 8.867 Millions	$ 3 Millions
10x Genomics Inc	3.21	$ 193.000 Millions	$ 60 Millions
Iovance Biotherapeutics inc	3.14	$ 165.941 Millions	$ 53 Millions
Lftd Partners Inc	3.12	$ 28.258 Millions	$ 9 Millions
Prestige Consumer Healthcare Inc	3.11	$ 493.000 Millions	$ 159 Millions
Beyond Air Inc	3.07	$ 6.521 Millions	$ 2 Millions
Bausch Health Companies Inc	3.07	$ 2,987.000 Millions	$ 974 Millions
Indivior Pharmaceuticals Inc	3.03	$ 242.000 Millions	$ 80 Millions
Amneal Pharmaceuticals Inc	3.02	$ 1,868.000 Millions	$ 618 Millions
Logicmark Inc	3.01	$ 3.826 Millions	$ 1 Millions
Mettler toledo International Inc	3.01	$ 1,189.678 Millions	$ 395 Millions
Revvity Inc	3.00	$ 1,151.379 Millions	$ 384 Millions
Cannapharmarx Inc	2.98	$ 2.921 Millions	$ 1 Millions
Becton Dickinson And Company	2.97	$ 11,368.000 Millions	$ 3,821 Millions
Dexcom Inc	2.97	$ 1,854.000 Millions	$ 624 Millions
Msa Safety Inc	2.93	$ 1,020.000 Millions	$ 349 Millions
Nexgel Inc	2.92	$ 6.000 Millions	$ 2 Millions
Abbott Laboratories	2.91	$ 19,741.000 Millions	$ 6,785 Millions

Date modified: 2026-08-29T17:23:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.